Saturday, October 10, 2020 LIVE ONLINE EVENT

Healthcare Professional Program

7:00 AM – 2:10 PM Patient-Centered Program

2:15 PM – 4:10 PM

Conference on Lung Cancer 2020: a CME-accredited,

1-day educational conference

The 7th Annual

TMM

Educational Partners

7:00 AM - 8:00 AM Exhibits and Pre-Course Ancillary Events 8:00 - 8:10 AM Opening Remarks 8:10 - 8:30 AM TALK 1: Minimally Invasive Techniques

in the Diagnosis and Staging of NSCLC — Dr. Ajay Wagh, University of Chicago

8:30 – 9:00 AM TALK 2: Key Considerations and Updates in the Management of Early Stage NSCLC

— Dr. Elizabeth Marshall, St. Peter's Health Partners [Thoracic Surgery] — Dr. Justin Juliano, NYOH [Radiation Oncology] 9:00 – 9:20 AM TALK 3: Updates in the Management of Locally-advanced NSCLC — Dr. Nischala Ammannagari, NYOH

9:20 – 9:40 AM Exibitor Break 9:40 – 10:10 AM Multidisciplinary Panel: Q&A MODERATOR: Dr. Makenzi Evangelist PANEL: Dr. Marshall, Dr. Juliano, Dr. Ammannagari, Dr. Wagh 10:10 – 10:30 AM TALK 4: Pathology: Biomarker Testing in the Management of NSCLC — Dr. Alex Spira, Virginia Cancer Specialists

10:30 - 11:00 AM TALK 5: New Advancements in Established Molecular Driver Mutations — Dr. Ibiayi Dagogo-Jack, MGH

11:00 - 11:30 AM TALK 6: Emerging Molecular Targets for NSCLC — Dr. Paul Paik, MSKCC

11:30 – 11:40 AM Exhibitor Break 11:40 AM – 12:40 PM Tentative Ancillary Event 12:40 – 1:25 PM KEYNOTE: Established and Emerging Approaches to Immunotherapy for Lung Cancer — Dr. Jamie Chaft, MSKCC 1:25 – 2:10 PM Case-based Panel Discussion Moderator: Dr. Makenzi Evangelist

2:15 – 2:20 PM Opening Remarks 2:20 – 2:50 PM Educational Session: Lung Cancer 101 2:50 – 3:20 PM Panel Discussion: Meet the Experts with Update on Recent Advances Moderator: Dr. Makenzi Evangelist, NYOH 3:20 – 3:30 PM Educational Resources 3:30 – 4:00 PM Supportive Care and Advocacy Panel — Patients, Caregivers, Advocacy, Social Work Palliative Care 4:00 – 4:10 PM Closing Remarks

HEALTHCARE PROFESSIONAL PROGRAM

Hosted By Organized By

Accredited Provider

PROGRAM DESCRIPTION

The focus of the 2020 Spring to Life Conference is Lung Cancer. New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of lung cancer. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc. and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported, educational conference. This is the seventh of these annual conferences that include programming for cancer clinicians.

The theme of the patient program is Breathing Space: Community Dialogues

on Living with Lung Cancer

Healthcare professionals are welcome and encouraged to participate in the afternoon patient-centered sessions.

This activity is accredited for 4.5

continuing education credits

Information and free registration: http://spring2liferegistration.org/

The Conference is being held in Eastern Daylight Time

Breathing Space: Community Dialogues on Living with Lung Cancer

LEARNING OBJECTIVES

After completing this activity, participants will be able to: n Describe current and evolving management strategies for patients

with localized and locally advanced, non-small cell lung cancer. n Identify best practices in biomarker testing and the utilization

of biomarkers to drive treatment decisions for patients with lung cancer.

n Explain the application of targeted therapy and immunotherapy in the treatment of NSCLC.

n Outline the clinical trial data on the use of molecular drivers in the management of patients with advanced, non-small cell lung cancer.

n Summarize current and emerging strategies in the management of patients with advanced, non-small cell lung cancer without driver mutations.

CONFERENCE PLATFORM The conference is being held online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A panel discussions. The sponsors and exhibitors of the conference will be available for attendees to visit during the duration of the conference in the Virtual Trade Show hall. The conference will be recorded and will be offered on-demand for 30 days following the conference.

PLANNING COMMITTEE

Ira Zackon, MD (Chair) New York Oncology Hematology—President Hematologist/Medical Oncologist NYOH Hematology Stem Cell Transplant Program NYOH Albany Medical Center Clinical Assistant Professor, Albany Medical College Albany, NY

Nischala Ammannagari, MD Medical Oncologist/Hematologist NYOH Albany Cancer Center Albany, NY

Makenzi Evangelist, MD Medical Oncologist/Hematologist NYOH Albany Medical Center Hematology/Oncology Division Head Albany Medical Center Clinical Assistant Professor, Albany Medical College Albany, NY

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider-ship of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT: The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

ASSURANCE OF BALANCED, UNBIASED, AND FAIR CONTENT: It is the policy of The University of Chicago Pritzker School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its individually provided or jointly provided educational activities. Individuals who are in a position to control the content of any educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.

EDUCATIONAL GOAL

The purpose of this conference is to educate practitioners and update their knowledge of existing and emerging therapies for the management of patients with lung cancer.

TARGET AUDIENCE

The target audience for this conference is medical oncologists, radiation oncologists, surgical oncologists, thoracic surgeons, pulmonologists, radiologists, interventional radiologists, pathologists, oncology nurses, advanced practice providers, family and primary care practitioners, allied health professionals, and any other individuals with an interest in the care of patients with lung cancer.

Information and free registration: http://spring2liferegistration.org/

Proudly Hosted By